Acceleration of casein induced amyloidosis in mice by immunosuppressive agents.
D000682:Amyloid / Q000032:analysis / Q000096:biosynthesis*; D000686:Amyloidosis / Q000139:chemically induced*; D000818:Animals; D001379:Azathioprine / Q000494:pharmacology; D002066:Busulfan / Q000494:pharmacology; D002364:Caseins; D002701:Chloramphenicol / Q000494:pharmacology; D003348:Cortisone / Q000494:pharmacology; D004247:DNA / Q000096:biosynthesis; D003609:Dactinomycin / Q000494:pharmacology; D003630:Daunorubicin / Q000494:pharmacology; D005260:Female; D005472:Fluorouracil / Q000494:pharmacology; D007166:Immunosuppressive Agents / Q000494:pharmacology*; D008099:Liver / Q000032:analysis; D008297:Male; D015122:Mercaptopurine / Q000494:pharmacology; D008727:Methotrexate / Q000494:pharmacology; D051379:Mice; D012313:RNA / Q000096:biosynthesis; D013154:Spleen / Q000032:analysis; D014747:Vinblastine / Q000494:pharmacology
D000682:Amyloid; D002364:Caseins; D007166:Immunosuppressive Agents; D003609:Dactinomycin; D014747:Vinblastine; D012313:RNA; D002701:Chloramphenicol; D004247:DNA; D015122:Mercaptopurine; D002066:Busulfan; D001379:Azathioprine; D005472:Fluorouracil; D003348:Cortisone; D008727:Methotrexate; D003630:Daunorubicin